Clinical Trial Update: Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating erlotinib alone or in combination with radiation therapy in pediatric patients with refractory/relapsed malignant brain tumo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Stem Glioma
• Brain Tumors

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: Children's Cancer and Leukaemia Group | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: UNKNOWN